ES8801130A1 - Metodo para la produccion de un sistema de aplicacion endonasal - Google Patents

Metodo para la produccion de un sistema de aplicacion endonasal

Info

Publication number
ES8801130A1
ES8801130A1 ES555676A ES555676A ES8801130A1 ES 8801130 A1 ES8801130 A1 ES 8801130A1 ES 555676 A ES555676 A ES 555676A ES 555676 A ES555676 A ES 555676A ES 8801130 A1 ES8801130 A1 ES 8801130A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
nasal pharmaceutical
nasal
calcitonin
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES555676A
Other languages
English (en)
Other versions
ES555676A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8801130A1 publication Critical patent/ES8801130A1/es
Publication of ES555676A0 publication Critical patent/ES555676A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO PARA LA PRODUCCION DE UN SISTEMA DE APLICACION ENDONASAL, QUE CONTIENE DISPERSADO UN AGENTE FARMACOLOGICAMENTE ACTIVO. COMPRENDE LAS OPERACIONES DE PRODUCIR UNA DISTRIBUCION DE UN AGENTE FARMACOLOGICAMENTE ACTIVO, EN UNA MATRIZ POROSA QUE COMPRENDE GELATINA O HIDROXIPROPILMETILCELULOSA, PREFERENTEMENTE POR COMBINACION DE UNA SOLUCION DEL AGENTE ACTIVO, TAL COMO EN ALCOHOL O AGUA, CON LA MATRIZ O CON UNA SOLUCION DE UNA MATRIZ POLIMERA A TEMPERATURA AMBIENTE; DE DISTRIBUIR UNA CALCITONINA EN UN SISTEMA DE APLICACION ENDONASAL, POR EJEMPLO IMPREGNANDO UNA ESPONJA CON UNA SOLUCION ACUOSA A TEMPERATURA AMBIENTE; Y DE ELIMINAR POR EVAPORACION EL DISOLVENTE. DE APLICACION EN EL TRATAMIENTO DE LA ENFERMEDAD DE PAGET, LA HIPERCALCEMIA Y LA OSTEOPOROSIS.
ES555676A 1985-06-04 1986-06-03 Metodo para la produccion de un sistema de aplicacion endonasal Expired ES8801130A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858514090A GB8514090D0 (en) 1985-06-04 1985-06-04 Organic compounds

Publications (2)

Publication Number Publication Date
ES8801130A1 true ES8801130A1 (es) 1988-01-01
ES555676A0 ES555676A0 (es) 1988-01-01

Family

ID=10580163

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555676A Expired ES8801130A1 (es) 1985-06-04 1986-06-03 Metodo para la produccion de un sistema de aplicacion endonasal

Country Status (21)

Country Link
US (1) US4988512A (es)
JP (1) JPS61282320A (es)
KR (1) KR870000066A (es)
AU (1) AU5824786A (es)
BE (1) BE904863A (es)
CH (1) CH668913A5 (es)
DE (1) DE3617728A1 (es)
DK (1) DK259186A (es)
ES (1) ES8801130A1 (es)
FR (1) FR2582511B1 (es)
GB (3) GB8514090D0 (es)
GR (1) GR861422B (es)
HU (1) HU199300B (es)
IL (1) IL78980A0 (es)
IT (1) IT1214683B (es)
LU (1) LU86457A1 (es)
NL (1) NL8601285A (es)
NZ (1) NZ216393A (es)
PT (1) PT82691B (es)
SE (1) SE8602530L (es)
ZA (1) ZA864164B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
CA2109794A1 (en) * 1991-05-24 1992-11-26 Timothy J. Rink Amylin and possibly insulin containing composition for the treatment of anorexia and related states
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
AU3343093A (en) * 1992-01-17 1993-08-03 Alfatec-Pharma Gmbh Pellets containing peptide drugs, their manufacture and use
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
WO1999040966A1 (en) * 1998-02-13 1999-08-19 Graham Francois Duirs Drug delivery system
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
WO2004084859A2 (en) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20070166382A1 (en) * 2004-03-26 2007-07-19 Kiser Patrick F Bioresponsive polymer system for delivery of microbicides
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US820948A (en) * 1905-01-23 1906-05-22 Edward Baum Device fot treating the nasal passages.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE1617564A1 (de) * 1966-12-03 1971-04-01 Rudolf Kisro Arzneimitteltraeger
DK135268A (es) * 1973-02-09
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) * 1980-06-12 1982-01-13 Toshiba Corp Recording and reproducing device
GB2090535B (en) * 1981-01-06 1984-09-19 Osman Mohammad Fekry Medical inserts
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules

Also Published As

Publication number Publication date
ZA864164B (en) 1988-01-27
GB8613284D0 (en) 1986-07-09
AU5824786A (en) 1986-12-11
LU86457A1 (fr) 1987-01-13
US4988512A (en) 1991-01-29
BE904863A (fr) 1986-12-03
SE8602530L (sv) 1986-12-05
CH668913A5 (de) 1989-02-15
IL78980A0 (en) 1986-09-30
NL8601285A (nl) 1987-01-02
SE8602530D0 (sv) 1986-06-04
NZ216393A (en) 1989-08-29
DK259186A (da) 1986-12-05
DK259186D0 (da) 1986-06-02
GR861422B (en) 1986-10-01
KR870000066A (ko) 1987-02-16
HUT49288A (en) 1989-09-28
GB2176105A (en) 1986-12-17
FR2582511A1 (fr) 1986-12-05
DE3617728A1 (de) 1986-12-04
ES555676A0 (es) 1988-01-01
PT82691B (en) 1988-05-03
GB8906584D0 (en) 1989-05-04
HU199300B (en) 1990-02-28
GB2213377A (en) 1989-08-16
IT1214683B (it) 1990-01-18
PT82691A (en) 1986-07-01
JPS61282320A (ja) 1986-12-12
GB2176105B (en) 1990-03-07
GB8514090D0 (en) 1985-07-10
IT8648098A0 (it) 1986-06-04
FR2582511B1 (fr) 1989-05-26

Similar Documents

Publication Publication Date Title
ES8801130A1 (es) Metodo para la produccion de un sistema de aplicacion endonasal
IL79887A0 (en) Human insulin analogues,their preparation and pharmaceutical compositions containing them
DE3665717D1 (en) Complexes of flavanolignanes with phospholipids, preparation thereof and associated pharmaceutical compositions
IL79323A0 (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
IL90550A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL89427A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL89904A0 (en) Vitamin d analogues and pharmaceutical compositions containing them
IL80846A0 (en) Calcitonin derivatives,their preparation and pharmaceutical compositions containing them
GB2171103B (en) Novel peptides and peptide derivatives, their preparation and use and pharmaceutical compositions containing them
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
ZA862416B (en) Composition for delivery of orally administered drugs and other substances
IL87871A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL80232A0 (en) N-substituted diphenylpiperidines,their manufacture and pharmaceutical compositions containing them
IL79792A0 (en) Amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL79642A0 (en) Benzimidazole derivatives,their manufacture and pharmaceutical compositions containing them
IL79469A0 (en) Substituted benzamides,their preparation and pharmaceutical compositions containing them
ZA86936B (en) 11beta-phenyl-gonanes,their manufacture and pharmaceutical preparations containing them
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
IL81010A0 (en) Substituted benzamides,their preparation and pharmaceutical compositions containing them
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL79497A0 (en) Acylphosphorotriamides and pharmaceutical compositions containing them
IL78918A (en) Spiroheterocyclically-condensed hexahydroaryl-quinolizines and pharmaceutical compositions containing them
IL79241A0 (en) Benzamides,their preparation and pharmaceutical compositions containing them